BackBellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Overview

Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Selling, General & Admin

See how BLACR's SG&A expenses trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$3.83M
23.99% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$19.67M
219.27% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 (BLACR) FAQ

Stockcircle tracks selling, general & admin for Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 (BLACR), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main BLACR overview so you can move from this figure to the surrounding analysis quickly.